Sign in

    Raymond J. Tesi

    President and Chief Executive Officer at INmune Bio Inc
    Board
    Since September 2015
    Age
    68 years
    Education
    Earned his MD degree from Washington University School of Medicine in 1982.
    Tenure
    Joined INmune Bio in September 2015 as President, Chief Executive Officer, and board member, maintaining his leadership role since the company's formation.

    Also at INmune Bio Inc

    DJM
    David J. Moss
    Chief Financial Officer

    About

    Dr. Raymond J. Tesi, who is 68 years old as of December 31, 2023 , has established a distinguished career in the biopharmaceutical industry. He earned his MD degree from Washington University School of Medicine in 1982 , forming the foundation of his medical expertise.

    In September 2015, he joined INmune Bio as President, Chief Executive Officer, and a board member, a role he has maintained ever since. This leadership position has enabled him to drive the company’s strategic direction and operational growth.

    Prior to his current appointment, his career included pivotal roles at FPRT Bio Inc. as CEO, President, and Acting Chief Medical Officer, at Adienne SRL as Chief Medical Officer, and as founder, CEO, and President of Coronado Biosciences.

    His extensive professional experience is further highlighted by his current board membership at Bexion Pharmaceuticals, underscoring a career marked by both clinical and entrepreneurial success in advancing medical innovation.

    $INMB Performance Under Raymond J. Tesi

    Past Roles

    OrganizationRoleDate RangeDetails
    FPRT Bio Inc. CEO, President, and Acting Chief Medical Officer November 2011 - May 2015 Development stage biotech focused on developing XPro1595 for neurodegenerative and inflammatory diseases
    Adienne SRL Chief Medical Officer November 2010 - October 2011 Emerging biotech in Bergamo, Italy focused on hematologic malignancy treatments
    Coronado Biosciences Founder, CEO, and President June 2007 - September 2010 N/A

    External Roles

    OrganizationRoleDate Range
    Bexion Pharmaceuticals Board Member N/A

    Fixed Compensation

    Data from  FY 2023
    Component NameAmount ($)Payment ScheduleAdditional Details
    Salary500,500 Annual Base salary for his role as CEO and President
    All Other Compensation0 Annual No additional compensation under this category for 2023

    Performance Compensation

    Data from  FY 2023

    No information available on performance compensation for 2023